磺达嗪INN:sulforidazine)是一种典型抗精神病药硫利达嗪英语Thioridazine代谢产物。它与美索达嗪英语Mesoridazine都比母体化合物更有效,这表明了硫利达嗪的药理反应可能主要是其代谢产生活性化合物的结果。[1]

磺达嗪
臨床資料
ATC碼
  • 未分配
识别信息
  • 102-[(RS)-1-Methylpiperidin-2-yl]ethyl2-(methylsulfonyl)-10H-phenothiazine
CAS号14759-06-9  checkY
PubChem CID
ChemSpider
UNII
ChEBI
ChEMBL
CompTox Dashboard英语CompTox Chemicals Dashboard (EPA)
ECHA InfoCard100.035.274 編輯維基數據鏈接
化学信息
化学式C21H26N2O2S2
摩尔质量402.57 g·mol−1
3D模型(JSmol英语JSmol
  • O=S(=O)(c2cc1N(c3c(Sc1cc2)cccc3)CCC4N(C)CCCC4)C
  • InChI=1S/C21H26N2O2S2/c1-22-13-6-5-7-16(22)12-14-23-18-8-3-4-9-20(18)26-21-11-10-17(15-19(21)23)27(2,24)25/h3-4,8-11,15-16H,5-7,12-14H2,1-2H3 checkY
  • Key:FLGCRGJDQJIJAW-UHFFFAOYSA-N checkY

合成

编辑
 
Thieme 合成:[2]专利:[3]

参考资料

编辑
  1. ^ Niedzwiecki DM, Mailman RB, Cubeddu LX. Greater potency of mesoridazine and sulforidazine compared with the parent compound, thioridazine, on striatal dopamine autoreceptors. Journal of Pharmacology and Experimental Therapeutics. March 1984, 228 (3): 636–9. PMID 6707914. 
  2. ^ Morrow, Ryan J.; Millership, Jeff S.; Collier, Paul S. (2005). "Facile Syntheses of the Three Major Metabolites of Thioridazine". Helvetica Chimica Acta. 88 (5): 962–967. doi:10.1002/hlca.200590089.
  3. ^ FR1363683 idem Bruschweiler Conrad, Schwarb Gustav, Winkler Hans, Renz Jany, 美國專利第3,314,948号 (1967 to Sandoz Ltd).